MetaCap

Pacific Biosciences of California Statistics

NASDAQ: PACBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

1.63-0.13 (-7.39%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pacific Biosciences of California by the numbers

Pacific Biosciences of California has a market capitalization of $508.9 million based on 312.24M shares outstanding. With trailing EPS of $-0.42, Pacific Biosciences of California is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.6% below its 50-day average and 2.2% above its 200-day average.

Average daily trading volume is 13.23M shares, or about $21.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PACB valuation vs. peer median

PACB compared with the median of 8 peer companies
MetricPACBPeer medianDifference
Market cap$508.95M$84.48M+502%
Avg. volume13.23M649.32K+1937%

Peer median across 8 companies: NAUT, LAB, CTKB, QTRX, SEER, HBIO, RPID, PRPO.

Valuation

Market cap
$508.95M
Price / sales (latest FY)
3.18
EPS (TTM)
$-0.42

Price and trading

Previous close
1.76
Open
1.69
Day range
1.61 – 1.73
52-week range
1.07 – 3.44
52-week change
-26.58%
Beta
—
Volume
13.68M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
508.95M
Forward Pe
-4.06
Eps
-0.42
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.44
Week52 Low
1.07
Avg Volume
13.23M
Shares Outstanding
312.24M
Ma50
2.05
Ma200
1.60
Earnings Date
Nov 4, 2026
Pct From52w High
-52.62%
Pct From52w Low
52.34%

Related